Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function (Q28569690)

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Mechanism of cytotoxicity by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Processing and presentation of antigens by dendritic cells: implications for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

IL-2 mediates adjuvant effect of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Induction of nitric oxide production by the peritoneal macrophages after intraperitoneal or subcutaneous transplantation of AK-5 tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2

Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing fas-ligand: a mechanism of immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900026-2